Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2020-08-25 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-VINCENT-DE-TYROSSE (40230), Landes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA FOUGERE : revenue, balance sheet and financial ratios
PHARMACIE DE LA FOUGERE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-VINCENT-DE-TYROSSE (40230),
this company of category PME
shows in 2025 a net income positive of 342 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA FOUGERE (SIREN 888304409)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
341 694 €
314 403 €
369 925 €
432 792 €
152 875 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA FOUGERE generates positive net income of 342 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 153 k€ -> 342 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
341 694 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 111%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
110.925%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.716%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA FOUGERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
1226.676
416.892
244.119
170.809
110.925
Financial autonomy
5.314
16.799
26.91
34.135
43.716
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
110.922025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA FOUGERE (110.92) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
43.72%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+13 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA FOUGERE (43.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 238.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
238.529
Liquidity indicators evolution PHARMACIE DE LA FOUGERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
2025
Liquidity ratio
91.064
150.133
242.56
365.105
238.529
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
238.532025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good
In 2025, the liquidity ratio of PHARMACIE DE LA FOUGERE (238.53) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE LA FOUGERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA FOUGERE is estimated at
5 427 849 €
(range 3 683 364€ - 8 517 043€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3683k€5427k€8517k€
5 427 849 €Range: 3 683 364€ - 8 517 043€
NAF 5 année 2025
Valuation method used
Net Income Multiple
341 694 €
×
15.9x
=5 427 850 €
Range: 3 683 365€ - 8 517 044€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA FOUGERE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA FOUGERE
What is the revenue of PHARMACIE DE LA FOUGERE ?
The revenue of PHARMACIE DE LA FOUGERE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA FOUGERE profitable?
Yes, PHARMACIE DE LA FOUGERE generated a net profit of 342 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA FOUGERE ?
The headquarters of PHARMACIE DE LA FOUGERE is located in SAINT-VINCENT-DE-TYROSSE (40230), in the department Landes.
Where to find the tax return of PHARMACIE DE LA FOUGERE ?
The tax return of PHARMACIE DE LA FOUGERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA FOUGERE operate?
PHARMACIE DE LA FOUGERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart